go to contents

Akribes Biomedical GmbH

Back to list

Facts

Founded
Staff
5
Organization type
RDM medtech

Profile

Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.

Similar companies in RDM medtech

Bucinator e. U.

Organization type
RDM medtech
Region
Tyrol
Topic
hospital hardware
telemedicine and e-health
software for medicine
Details

EMTensor GmbH

Organization type
RDM medtech
Region
Vienna
Details

A.M.I. Agency for Medical Innovations GmbH

Organization type
RDM medtech
Region
Vorarlberg
Topic
electromechanical medical devices
Other
single-use devices
resuable devices
non-active implantable devices
Details

a.tron3d GmbH

Organization type
RDM medtech
Region
Carinthia
Topic
dental devices
Details

Contact



Contact: